Saltar al contenido
Merck

Giant prolactinomas presenting as skull base tumors.

Surgical neurology (2002-03-21)
Giuseppe Minniti, Marie Lise Jaffrain-Rea, Antonio Santoro, Vincenzo Esposito, Luigi Ferrante, Roberto Delfini, Giampaolo Cantore
RESUMEN

Prolactinomas invading the skull base are rare, and could easily be confused with skull base tumors of nonpituitary origin. We report a series of 4 cases of giant prolactinomas invading the skull base and presenting with atypical symptoms. Case 1 presented with a short history of headache and nasal obstruction. Case 2 presented with progressive hypoacusia, dizziness, and ophthalmoplegia. In Case 3, the patient developed rapid progressive visual failure and psychiatric symptoms. Case 4 presented with a 1-year history of headache and retrorbital pain. The diagnosis of prolactinoma was made on the basis of tumor immunohistochemistry and/or high plasma prolactin levels (range from 650-6,500 ng/mL). Medical treatment with the dopamine agonist cabergoline was given; it was effective in normalizing prolactin levels and inducing tumor shrinkage. Prolactin levels should be measured in all large skull base tumors involving the pituitary region before any surgery or inappropriate radiotherapy is performed.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Prolactin (EP193) Rabbit Monoclonal Primary Antibody